title: Pertuzumab-induced cardiotoxicity: safety compared with trastuzumab.
authors.affiliation: Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Oncology, 06800, Ankara, Turkey.
authors.forename: Mehmet A N
authors.initials: MA
authors.lastname: Sendur
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D066126:Cardiotoxicity / Q000209:etiology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C485206:pertuzumab
keywords: HER2; breast cancer; pertuzumab; pertuzumab-induced cardiotoxicity; trastuzumab; trastuzumab-induced cardiotoxicity